title: Squamous cell carcinomas of the skin responsive to erlotinib: 5 cases.
authors.affiliation: Department of Hematology/Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.
authors.forename: William L
authors.initials: WL
authors.lastname: Read
authors.affiliation: Moores Cancer Center, UC San Diego Health System, La Jolla, California.
authors.forename: Kevin T
authors.initials: KT
authors.lastname: Brumund
authors.affiliation: Moores Cancer Center, UC San Diego Health System, La Jolla, California.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Weisman
authors.affiliation: Moores Cancer Center, UC San Diego Health System, La Jolla, California.
authors.forename: Angel Q
authors.initials: AQ
authors.lastname: Nguyen
keywords: CR, complete response; EGFR, epidermal growth factor receptor; EGFRi, epidermal growth factor receptor inhibitors; SCCS, squamous cell cancers of skin; epidermal growth factor receptor; epidermal growth factor receptor inhibitor; erlotinib; mTOR, mechanistic target of rapamycin; squamous cell carcinoma of the skin